Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP),
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …

This update and revision of the international guideline for urticaria was developed following
the methods recommended by Cochrane and the Grading of Recommendations …

This evidence‐and consensus‐based guideline was developed following the methods
recommended by Cochrane and the Grading of Recommendations Assessment …

This guideline is the result of a systematic literature review using the 'G rading of R
ecommendations A ssessment, D evelopment and E valuation'(GRADE) methodology and a …

This guideline, together with its sister guideline on the classification of urticaria (Zuberbier T,
Asero R, Bindslev‐Jensen C, Canonica GW, Church MK, Giménez‐Arnau AM et al …

Injection of autologous serum collected during disease activity from some patients with
chronic spontaneous urticaria (CU) into clinically normal skin elicits an immediate weal and …

Urticaria and angioedema are common clinical conditions representing a major concern for
physicians and patients alike. The World Allergy Organization (WAO), recognizing the …

Chronic spontaneous urticaria (CSU) is defined as the appearance of evanescent wheals,
angioedema, or both, for at least 6 weeks. CSU is associated with intense pruritus and poor …

Chronic spontaneous urticaria (CSU) is a condition in which wheals, angioedema, and
pruritus occur spontaneously and recurrently for at least 6 weeks. The etiology of this …